Rigel Pharmaceuticals (RIGL) PT Lowered to $20.45 at Jefferies
Tweet Send to a Friend
Jefferies analyst Eun Yang lowered the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $20.45 (from $23.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
